OMICS Publishing Group

HDAI to Present at ViVE 2024 on How Clinicians Can Put AI to Work

Retrieved on: 
Monday, February 26, 2024

BOSTON, Feb. 26, 2024 /PRNewswire/ -- Health Data Analytics Institute (HDAI) – a company pioneering the integration of artificial intelligence into healthcare delivery, today announced their upcoming ViVE 2024 conference presentation - "The Cleveland Clinic Vision: How Clinicians Can Put AI to Work for Better Care".

Key Points: 
  • BOSTON, Feb. 26, 2024 /PRNewswire/ -- Health Data Analytics Institute (HDAI) – a company pioneering the integration of artificial intelligence into healthcare delivery, today announced their upcoming ViVE 2024 conference presentation - "The Cleveland Clinic Vision: How Clinicians Can Put AI to Work for Better Care".
  • ViVE 2024 conference presentation - "The Cleveland Clinic Vision: How Clinicians Can Put AI to Work for Better Care".
  • The speakers will discuss their collaboration in deploying HealthVision™, a predictive analytics and generative AI platform.
  • "AI technology can help clinicians make better decisions that improve patient outcomes while reducing time spent searching in the electronic health record (EHR)," said Chamoun.

Children's Health and UT Southwestern Announce Plans for Transformative New Pediatric Campus in Dallas' Southwestern Medical District

Retrieved on: 
Wednesday, February 7, 2024

DALLAS, Feb. 7, 2024 /PRNewswire/ -- Children's HealthSM and UT Southwestern Medical Center unveiled plans for a new $5 billion pediatric health campus in Dallas' Southwestern Medical District today. Spanning more than 33 acres, the new pediatric campus offers a patient-centric design that can meet the rapidly increasing need for more pediatric services from the most common to the most complex. It will serve as a joint hub for innovation, academic research and training, and the development of life-saving technologies to provide exemplary care for the youngest members of our community.

Key Points: 
  • New Multi-tower Hospital to Replace Children's Medical Center Dallas to Meet Surging Demand for Pediatric Care, Research and Training
    DALLAS, Feb. 7, 2024 /PRNewswire/ -- Children's HealthSM and UT Southwestern Medical Center unveiled plans for a new $5 billion pediatric health campus in Dallas' Southwestern Medical District today.
  • Life-changing treatments, pioneering research, and training the next generation of pediatric providers are the hallmarks of the Children's Health and UT Southwestern legacy.
  • The new pediatric campus adds to the ongoing investments Children's Health continues to make to meet the region's growing pediatric medical and surgical needs.
  • In 2025, Children's Health will occupy the second floor of the 150,000-square-foot UT Southwestern Medical Center at RedBird, part of the Reimagine RedBird development.

PM PEDIATRIC CARE ANNOUNCES KEVIN TREXLER AS NEW CHIEF EXECUTIVE OFFICER

Retrieved on: 
Thursday, January 11, 2024

LAKE SUCCESS, N.Y., Jan. 11, 2024 /PRNewswire/ -- PM Pediatric Care, the nation's largest provider of specialized pediatric urgent care and recognized leader in pediatric behavioral health, announced today the appointment of Kevin Trexler as Chief Executive Officer. Trexler will succeed Mr. Steven Katz and Dr. Jeffrey Schor, who co-founded the organization in 2005 and have served as co-CEOs to date. Their visionary plan to create a community based alternative to children's emergency departments has grown to become a vast network providing care for well over a million children and young adults each year. They will serve as Board Members to continue advancement of the company's mission and growth.

Key Points: 
  • Former founding co-CEOs Steven Katz and Dr. Jeffrey Schor to continue serving as Board Members
    LAKE SUCCESS, N.Y., Jan. 11, 2024 /PRNewswire/ -- PM Pediatric Care, the nation's largest provider of specialized pediatric urgent care and recognized leader in pediatric behavioral health, announced today the appointment of Kevin Trexler as Chief Executive Officer.
  • "It has been an honor and a privilege to lead as co-CEO of PM Pediatric Care since its inception in 2005," said Mr. Katz.
  • Kevin Trexler joins PM Pediatric Care with more than 25 years of leadership experience, most recently serving as CEO of SOL Mental Health.
  • "PM Pediatric Care is a world-class industry leader in pediatric care with enormous opportunity for growth and innovation.

Life Sciences IP Attorney Joins Patent Team at Panitch Schwarze

Retrieved on: 
Monday, November 27, 2023

PHILADELPHIA, Nov. 27, 2023 /PRNewswire-PRWeb/ -- Intellectual property law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce that Christopher L. North, Ph.D. joined the firm as counsel. Utilizing his extensive scientific background, North will focus his practice on litigation (in district court and before the Patent Trial and Appeal Board) as well as opinions, counseling, and prosecution matters.

Key Points: 
  • "We are thrilled to welcome Chris to the firm," said Panitch Schwarze partner Martin Belisario.
  • "He is extremely well-versed in a variety of scientific disciplines, as well as every step of the patent prosecution process.
  • Co-Chair of Panitch Schwarze's Post-Grant Group, partner Erin Dunston, said "Chris is a fantastic addition to our growing Life Sciences and Post-Grant teams.
  • "I am happy to join Panitch Schwarze's team of IP attorneys and support the cutting-edge research of our clients," said North.

Dyadic to Present at Industry and Investor Events in October

Retrieved on: 
Friday, September 29, 2023

JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be presenting at the following industry and investor events during the month of October:

Key Points: 
  • JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be presenting at the following industry and investor events during the month of October:
    Enzyme Engineering XXVII , October 1-6, 2023
    “Next Generation Proteins for World Health, Nutrition and Wellness”
    If you would like to connect with Dyadic’s management at any of the events, you may request a one-on-one meeting at [email protected] .

Sibylla Biotech Appoints Dominique Bridon as Executive Chairman of the Board

Retrieved on: 
Thursday, September 28, 2023

Sibylla Biotech today announces the appointment of Dominique Bridon, Ph.D., as Executive Chairman of its Board of Directors.

Key Points: 
  • Sibylla Biotech today announces the appointment of Dominique Bridon, Ph.D., as Executive Chairman of its Board of Directors.
  • Dr. Bridon brings more than 30 years of experience in operations as well as research and development in the pharmaceutical and biotechnology sectors.
  • As an expert in implementing AI-based technologies for drug development and with a broad knowledge base in precision oncology, Dr. Bridon has successfully led drug discovery efforts from conception to clinical development.
  • Joining Sibylla, Dr. Bridon will contribute his expertise and lead the Board as Sibylla expands its proprietary pipeline of innovative protein degraders.

Pediatric Dental Care of Memphis Welcomes Dr. Jacob Stegeman, Announces New Location, Updated Website

Retrieved on: 
Monday, July 31, 2023

MEMPHIS, Tenn., July 31, 2023 /PRNewswire-PRWeb/ -- Pediatric Dental Care of Memphis is pleased to announce the addition of Dr. Jacob Stegeman to its team of pediatric dentists. Along with the addition of Dr. Stegeman, Pediatric Dental Care of Memphis opened a new location in White Station and also launched a new website, located at https://www.pdocforkids.com.

Key Points: 
  • Pediatric Dental Care of Memphis is pleased to announce the addition of Dr. Jacob Stegeman to its team of pediatric dentists.
  • MEMPHIS, Tenn., July 31, 2023 /PRNewswire-PRWeb/ -- Pediatric Dental Care of Memphis is pleased to announce the addition of Dr. Jacob Stegeman to its team of pediatric dentists.
  • Along with the addition of Dr. Stegeman, Pediatric Dental Care of Memphis opened a new location in White Station and also launched a new website, located at https://www.pdocforkids.com .
  • Pediatric Dental Care of Memphis is a premier pediatric dental clinic serving Memphis and the surrounding areas.

XpertDox and PM Pediatric Care Announce Partnership to Enhance Medical Coding Efficiency

Retrieved on: 
Thursday, June 22, 2023

BIRMINGHAM, Ala., June 22, 2023 /PRNewswire/ -- XpertDox, an AI-driven data analytics company, and PM Pediatric Care, the leading pediatric urgent care network in the US, are pleased to announce their strategic partnership. The collaboration will empower PM Pediatric Care to optimize its medical claims coding process by harnessing the power of XpertCoding, an autonomous medical coding engine developed by XpertDox.

Key Points: 
  • Collaboration between AI-driven data analytics company, XpertDox, and leading pediatric urgent care network, PM Pediatric Care, aims to enhance patient-centered care by leveraging XpertCoding, an autonomous medical coding engine.
  • BIRMINGHAM, Ala., June 22, 2023 /PRNewswire/ -- XpertDox, an AI-driven data analytics company, and PM Pediatric Care, the leading pediatric urgent care network in the US, are pleased to announce their strategic partnership.
  • The collaboration will empower PM Pediatric Care to optimize its medical claims coding process by harnessing the power of XpertCoding, an autonomous medical coding engine developed by XpertDox.
  • With this partnership, PM Pediatric Care will leverage XpertCoding to continue its focus on patient-centered care while substantially increasing its medical coding efficiency.

PM PEDIATRIC CARE ANNOUNCES $50M INVESTMENT FROM SCOPIA CAPITAL AND JEFFERSON RIVER CAPITAL

Retrieved on: 
Tuesday, June 20, 2023

LONG ISLAND, N.Y., June 20, 2023 /PRNewswire/ -- PM Pediatric Care, a nationally recognized leader in the delivery of pediatric care, announces $50M in Series E equity funding led by Scopia Capital, including Jefferson River Capital.

Key Points: 
  • LONG ISLAND, N.Y., June 20, 2023 /PRNewswire/ -- PM Pediatric Care, a nationally recognized leader in the delivery of pediatric care, announces $50M in Series E equity funding led by Scopia Capital, including Jefferson River Capital.
  • The company will also enhance its patient-centered infrastructure and explore additional pediatric service lines, including primary care, as it seeks to become a key component of value-based models of pediatric health care.
  • PM Pediatric Care has treated over 6.5 million patients in 78 urgent care locations across the U.S., as well as thousands of mental and behavioral health patients.
  • "We have never been more confident in the future of PM Pediatric Care," said Steve Katz, Co-Founder & Co-CEO of PM Pediatric Care.

What’s the latest on GMOs and gene-edited foods – and what are the concerns? An expert explains

Retrieved on: 
Tuesday, May 9, 2023

Advances in genetic engineering have given rise to an era of foods – including genetically modified organisms (GMOs) and gene-edited foods – that promise to revolutionise the way we eat.

Key Points: 
  • Advances in genetic engineering have given rise to an era of foods – including genetically modified organisms (GMOs) and gene-edited foods – that promise to revolutionise the way we eat.
  • What are GMOs and gene-edited foods?

GMOs and gene-edited foods aren’t the same

    • GMOs are organisms whose genetic material has been artificially altered by inserting a piece of foreign DNA.
    • Gene editing involves making precise changes to an organism’s genome without the integration of foreign DNA elements.
    • Although GMOs and gene-edited foods have been in circulation for almost three decades, research in this space continues to deliver breakthroughs.

What are the concerns?

    • GMOs are mainly used to produce crops that are herbicide-resistant or produce pesticides.
    • Farmers can then use herbicides on those crops to control weeds more effectively, without the plants themselves dying.
    • People raise concerns over potential long-term health impacts, impacts on biodiversity and ecosystems, and the increased corporate control over agriculture.

Is genetic modification itself unsafe?

    • Even among experts with genome-sequencing information, most have only one or a few sequenced “reference” varieties, and these often aren’t the same as the plants we eat.
    • The fact is, we don’t really understand the genomes of many plants and animals we eat.
    • Moreover, there’s currently no evidence regulator-approved GMOs or gene-edited foods aren’t safe for human consumption.

GMOs and gene-edited foods are widespread

    • Due to inconsistent rules about labelling GMOs and gene-edited foods around the world, many consumers may not realise they’re already eating them.
    • Historically, chymosin was extracted from young cow stomachs, but in the 1990s scientists managed to genetically engineer a bacterium to synthesise it.
    • GMOs and gene-edited cereal and oilseed products are also widely used in stockfeeds.
    • A simple gene edit can help inhibit the browning oxidation reaction, leading to a longer shelf-life and less food waste.

Regulation in Australia and New Zealand

    • In Australia, the Office of the Gene Technology Regulator regulates GMOs.
    • Gene-edited foods can be cultivated without any regulatory restrictions or labelling in Australia.
    • Divergent definitions have led the bi-national agency Food Standards Australia New Zealand (FSANZ) to adopt a cautious approach, regulating gene-edited foods and feeds as GMOs.

Responsible research


    Both GMOs and gene-edited foods offer great promise. Of course there are valid concerns, such as the potential to create new allergens, unintended consequences for ecosystems, and growing corporate control over food. But these can be addressed through responsible research and regulatory frameworks. Ultimately, the development of future foods must be guided by a commitment to sustainability, social justice and scientific rigour.